Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó, Govinda J. Weerakkody, Zhengyu Yang, John Doupis, Diego Aizenberg, Alan Wynne, Jeffrey S. Riesmeyer, Robert J. Heine, Russell J. Wiese, Andrew Ahmann, Samir Arora, Eric Ball, Rafael Burgos-Calderón, David Butuk, Leila Chaychi, Michael C. Chen, Brian M. Curtis, Ronald H. Chochinov, Christopher Chow, Clancy Cone, Lisa Connery, Gregorio Cortes-Maisonet, José de Souza, Kathleen Dungan, David Bradley, Juan P. Frías, Nashwa Gabra, Linda Gaudiani, Luis Herandez-Vazquez, Stanley H. Hsia, Michael Jardula, E. Klein, Mark E Kutner, Juan Loy, Francisco G Miranda, Lazaro Nunez, Miguel Mujica-Baella, Alexander V. Murray, Michael Oliver, Ramon Oritz-Carrasquillo, Betsy Palal, Michael T Parke, Athena Philis‐Tsimikas, Raman Purighalla, Julio Rosenstock, Airani Sathananthan, Courtney Shelton, Kanagaratnam Sivalingam, Ehab Sorial, Joseph Soufer, Helen L Stacey, Larry D. Stonesifer, Stanley Stringam, Joanna Van, Jose Vazquez-Tanus, Ramón López de los Reyes, Michelle Welch, Najmuddin Karimjee, Earl E Martin, Ahmed A. Arif, Timothy W Jennings, Neil J. Fraser, Anuj Bhargava, Alan Wynne, Evelyne Davidson, Liana K. Billings, Elizabeth A Barranco-Santana, Michael Dever, Patrick Walsh, A.K. Cho, James W. Chu, Jay H. Shubrook, Albert B. Knouse, Venkatesh Nadar, Lorena Lewy-Alterbaum, Michael Lillestol, Daniel J Humiston, Alexander White, Ronald K. Mayfield, Fahed Bitar, Fernando Cereto, Carmen de la Cuesta, L. de Teresa Parreño, Esteban Jódar Gimeno, Pedro Mezquita‐Raya, Cristobal J Morales Portillo, Miguel Quesada Charneco, Francisco J. Tinahones, Santiago Tofe Povedano, Luis Alberto Vázquez, Carmen Fajardo Montañana, Alfonso González, Cristina Mistodie, Iosif Szilagyi, Adriana Filimon, Nicoleta Mîndrescu, Lavinia Pop, Marlena Pascu